Efficacy of SGLT2 inhibitors as additional treatment in Japanese type 2 diabetic patients: second or third choice?

OBJECTIVES: Due to the increase of type 2 diabetes (T2D), the number of patients in treatment with multiple anti-diabetic agents is increased. According to the recent recommendation of treatment guidelines, sodium-glucose cotransporter 2 (SGLT2) inhibitors would be used as additional treatment to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Makoto, Shimizu, Masaru, Maejima, Yuko, Shimomura, Kenju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962121/
https://www.ncbi.nlm.nih.gov/pubmed/35351190
http://dx.doi.org/10.1186/s13104-022-06010-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962121/
https://www.ncbi.nlm.nih.gov/pubmed/35351190
http://dx.doi.org/10.1186/s13104-022-06010-6

Ejemplares similares